AMR Centre, Shionogi team up for superbug therapy - PharmaTimes
AMR Centre, Shionogi team up for superbug therapy PharmaTimes
The AMR Centre has announced a landmark agreement with the Japanese pharma company Shionogi to take forward its anti-virulence program, COT-143.
Comments
Post a Comment